ACELRX PHARMACEUTICALS INC entered into an Asset Purchase Agreement with Vertical Pharmaceuticals, LLC to sell certain assets and liabilities related to its sufentanil sublingual tablet product DSUVIA or DZUVEO, with potential sales-based milestones and royalty payments.